COMBINING THERAPEUTIC RESPONSE GENOMIC SIGNATURES WITH MACHINE LEARNING TO PREDICT PATIENT OUTCOME FROM POTENTIALLY LETHAL PROSTATE CANCER

Yale Univ

Investigators